Sign In
Buy RCEL
$4.16
-0.0300 (-0.716%)
At Close: Jun 03, 2026
AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference
05:30pm, Wednesday, 26'th Feb 2025
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time.
Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know
10:55am, Thursday, 20'th Feb 2025
The mean of analysts' price targets for Avita Medical (RCEL) points to a 52.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among an
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
12:01pm, Tuesday, 18'th Feb 2025
After Sales Rebound In January, AVITA Is Set Up For A Monster Year
AVITA Medical to Host Investor Webinar Briefing
09:15am, Friday, 14'th Feb 2025
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on February 18, 2025 at 2:00PM PT.
AVITA Medical, Inc. (RCEL) Q4 2024 Earnings Call Transcript
09:33pm, Thursday, 13'th Feb 2025
AVITA Medical, Inc. (NASDAQ:RCEL ) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Off
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
04:01pm, Thursday, 13'th Feb 2025
VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported fin
Investors Burned By AVITA Medical's Sales Miss: I'm Even More Bullish
10:52pm, Sunday, 12'th Jan 2025
AVITA Medical's stock plummeted 36.4% after a significant Q4 sales miss, highlighting a pattern of guidance misses. Management's breakeven target shifted to Q4 2025. It also gave 2025 sales guidance o
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini
06:28pm, Friday, 10'th Jan 2025
AVITA Medical: A Dip Buy As 2025 Looks Bullish With Cohealyx And RECELL GO Mini
Avita Medical Cuts Annual Sales Forecast On Softer Demand From Hospitals
01:06pm, Wednesday, 08'th Jan 2025
On Tuesday, Avita Medical, Inc. RCEL revised its revenue guidance for the fourth quarter and full year of 2024.
Avita Medical price target lowered to $14 from $20 at Lake Street
09:00am, Wednesday, 08'th Jan 2025
Lake Street analyst Brooks O'Neil lowered the firm's price target on Avita Medical to $14 from $20 and keeps a Buy rating on the shares after the company announced preliminary Q4 commercial revenue th
AVITA Medical, Quantum Computing And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:14am, Wednesday, 08'th Jan 2025
U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Wednesday.
AVITA Medical's shares sink 19% after another forecast cut
10:12pm, Tuesday, 07'th Jan 2025
AVITA Medical's Australia-listed shares sank nearly 19% on Wednesday, set for their worst day in 15 months, after the regenerative medicine firm cut its forecast for the fourth time in five quarters a
AVITA Medical Updates Expected Fourth Quarter and Full Year 2024 Revenue, Provides 2025 Financial Guidance
04:35pm, Tuesday, 07'th Jan 2025
AVITA Medical expects fourth quarter 2024 commercial revenue of approximately $18.4 million, reflecting growth of around 30% over the same period in 2023.
AVITA Medical Just Tripled Its TAM In The Burn Market
11:26am, Thursday, 02'nd Jan 2025
AVITA Medical's Q3 report showed strong sequential sales growth and a lower burn rate. My confidence in it reaching breakeven by Q3 2025 has increased. The transition to RECELL GO has been highly succ
AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds
04:02pm, Monday, 23'rd Dec 2024
VALENCIA, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care mana
